Sanda MG - Search Results

1

The polycomb group protein EZH2 is involved in progression of prostate cancer.

Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM. Varambally S, et al. Among authors: sanda mg. Nature. 2002 Oct 10;419(6907):624-9. doi: 10.1038/nature01075. Nature. 2002. PMID: 12374981 Free article. Clinical Trial.

2

Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice.

Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, Pienta KJ, Greenberg NM, Zeng Z, Sanda MG. Hsu CX, et al. Among authors: sanda mg. J Urol. 1998 Oct;160(4):1500-5. J Urol. 1998. PMID: 9751403

3

Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancer.

Sanda MG, Smith DC, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic D, Panicali D, Montie JE. Sanda MG, et al. Urology. 1999 Feb;53(2):260-6. doi: 10.1016/s0090-4295(98)00539-1. Urology. 1999. PMID: 9933036

4

Early castration reduces prostatic carcinogenesis in transgenic mice.

Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg NM, Hsu CX, Sanda MG. Eng MH, et al. Among authors: sanda mg. Urology. 1999 Dec;54(6):1112-9. doi: 10.1016/s0090-4295(99)00297-6. Urology. 1999. PMID: 10604719

5

Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.

Rubin MA, Bassily N, Sanda M, Montie J, Strawderman MS, Wojno K. Rubin MA, et al. Am J Surg Pathol. 2000 Feb;24(2):183-9. doi: 10.1097/00000478-200002000-00003. Am J Surg Pathol. 2000. PMID: 10680885

6

Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.

Marcovich R, Wojno KJ, Wei JT, Rubin MA, Montie JE, Sanda MG. Marcovich R, et al. Among authors: sanda mg. Urology. 2000 Jun;55(6):904-8. doi: 10.1016/s0090-4295(00)00451-9. Urology. 2000. PMID: 10840106

7

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors.

Shah R, Bassily N, Wei J, Mucci NR, Montie JE, Sanda MG, Rubin MA. Shah R, et al. Among authors: sanda mg. Urology. 2000 Nov 1;56(5):721-5. doi: 10.1016/s0090-4295(00)00775-5. Urology. 2000. PMID: 11068287

8

Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?

Rubin MA, Mucci NR, Manley S, Sanda M, Cushenberry E, Strawderman M, Montie JE, Bassily NH. Rubin MA, et al. J Urol. 2001 Jan;165(1):114-8. doi: 10.1097/00005392-200101000-00029. J Urol. 2001. PMID: 11125378

9

Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate.

Rashid MG, Sanda MG, Vallorosi CJ, Rios-Doria J, Rubin MA, Day ML. Rashid MG, et al. Among authors: sanda mg. Cancer Res. 2001 Jan 15;61(2):489-92. Cancer Res. 2001. PMID: 11212238

10

Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer.

Kielb SJ, Shah NL, Rubin MA, Sanda MG. Kielb SJ, et al. Among authors: sanda mg. J Urol. 2001 Aug;166(2):482-7. J Urol. 2001. PMID: 11458051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters